34 results
management pharmacology infections treatment prevention diagnosis ois antibiotics bacterial antimicrobial cdiff cryptococcus differential mycobacterium prophylaxis rhinosinusitis syndromes syndromic systems 1
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... 0.7–1.0 mg/kg IV ... Coccidiodomycosis #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS Preferred Therapy For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... rifampin 300 mg IV ... Bartonellosis #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... acyclovir 5 mg/kg IV ... HerpesSimplex #HSV #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... 0.7–1.0 mg/kg IV ... #Cryptococcus #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
IDSA Recommendations ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS Early Stage (Primary, Secondary,
IDSA Recommendations ... 3–4 million U IV ... Treponema #pallidum #IDSA ... Treatment #management #opportunistic ... #infections #HIVAIDS
No results found for "IV idsa opportunistic hivaids"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #IV #idsa #opportunistic #hivaids